Immix Biopharma, Inc.
IMMX · Pharmaceutical Preparations
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Adams Helen C.: Form 4
Insider disclosure · Filed · Report period 22 May 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- IMMX · 45258H106 - Common stock, $0.0001 par value
Company details and SEC sources
CIK 0001873835 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- IMMX on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 11400 West Olympic Blvd., Suite 200, Los Angeles, CA, 90064
- Incorporated in
- DE
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields